X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8077) 8077
Book Review (815) 815
Publication (228) 228
Magazine Article (38) 38
Book Chapter (29) 29
Book / eBook (11) 11
Conference Proceeding (9) 9
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7510) 7510
humans (6298) 6298
male (4566) 4566
cardiomegaly - etiology (3707) 3707
female (3514) 3514
adult (2594) 2594
middle aged (2523) 2523
cardiomegaly - complications (2349) 2349
animals (2253) 2253
abridged index medicus (1991) 1991
electrocardiography (1796) 1796
hypertension - complications (1784) 1784
cardiomegaly - physiopathology (1593) 1593
aged (1505) 1505
echocardiography (1249) 1249
cardiomegaly - pathology (1225) 1225
rats (1223) 1223
cardiac & cardiovascular systems (1146) 1146
cardiomegaly - diagnosis (1008) 1008
myocardium - pathology (956) 956
cardiomegaly - diagnostic imaging (942) 942
adolescent (934) 934
blood pressure (773) 773
child (762) 762
hypertrophy (699) 699
hypertension - physiopathology (674) 674
heart failure - etiology (614) 614
cardiomegaly - metabolism (582) 582
radiography (568) 568
hemodynamics (567) 567
hypertension (566) 566
heart (555) 555
infant (515) 515
myocardium - metabolism (515) 515
child, preschool (500) 500
peripheral vascular disease (499) 499
cardiomegaly - drug therapy (485) 485
heart - physiopathology (456) 456
cardiac catheterization (444) 444
time factors (444) 444
disease models, animal (440) 440
hypertension - drug therapy (436) 436
cardiomegaly (434) 434
myocardial infarction - complications (417) 417
mice (413) 413
heart ventricles (395) 395
heart failure (375) 375
diagnosis, differential (372) 372
cardiomegaly - prevention & control (362) 362
organ size (362) 362
risk factors (362) 362
infant, newborn (352) 352
heart failure - complications (345) 345
prognosis (345) 345
cardiac hypertrophy (331) 331
heart ventricles - physiopathology (325) 325
myocardial contraction (316) 316
follow-up studies (310) 310
blood pressure - drug effects (309) 309
heart-failure (304) 304
age factors (301) 301
heart ventricles - pathology (299) 299
coronary disease - complications (296) 296
chronic disease (293) 293
cardiovascular system (290) 290
pregnancy (287) 287
medicine, general & internal (283) 283
arrhythmias, cardiac - etiology (282) 282
heart enlargement (270) 270
physiology (269) 269
cardiomegaly - genetics (258) 258
fibrosis (257) 257
aortic valve stenosis - complications (255) 255
dogs (242) 242
cardiomyopathy (241) 241
rats, sprague-dawley (241) 241
heart failure - physiopathology (233) 233
left-ventricular hypertrophy (229) 229
heart rate (227) 227
pharmacology & pharmacy (226) 226
antihypertensive agents - therapeutic use (221) 221
angiocardiography (217) 217
cardiac output (211) 211
rats, inbred shr (211) 211
rodents (207) 207
heart diseases (205) 205
physiological aspects (204) 204
rats, inbred strains (204) 204
vectorcardiography (203) 203
rats, wistar (201) 201
body weight (194) 194
cardiac-hypertrophy (193) 193
autopsy (190) 190
cell biology (189) 189
disease (184) 184
coronary circulation (183) 183
oxidative stress (183) 183
heart valve prosthesis (179) 179
expression (178) 178
left ventricular hypertrophy (177) 177
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6205) 6205
German (368) 368
Russian (346) 346
Italian (317) 317
French (316) 316
Spanish (167) 167
Japanese (147) 147
Polish (53) 53
Portuguese (50) 50
Chinese (38) 38
Czech (30) 30
Romanian (25) 25
Hungarian (12) 12
Slovak (11) 11
Dutch (10) 10
Croatian (6) 6
Danish (6) 6
Serbian (6) 6
Bulgarian (5) 5
Hebrew (5) 5
Norwegian (3) 3
Finnish (2) 2
Ukrainian (2) 2
Korean (1) 1
Lithuanian (1) 1
Macedonian (1) 1
Persian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FASEB Journal, ISSN 0892-6638, 10/2014, Volume 28, Issue 10, pp. 4408 - 4419
Journal Article
1983, ISBN 0890048711, Volume 8., xvii, 366
Book
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 12/2015, Volume 468, Issue 1-2, pp. 221 - 227
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2016, Volume 11, Issue 3, pp. e0150745 - e0150745
Objective Although dipeptidyl peptidase-4 (DPP-4) inhibitors have been suggested to have a non-glucoregulatory protective effect in various tissues, the... 
TRANSITION | HYPERTROPHY | GLP-1 | MYOCARDIAL-INFARCTION | PROTECTION | MULTIDISCIPLINARY SCIENCES | EXENATIDE | INJURY | DPP-4 | Immunohistochemistry | Albuminuria - complications | Kidney - pathology | Apoptosis - drug effects | Albuminuria - blood | Cardiovascular Diseases - drug therapy | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | NADPH Oxidases - metabolism | Dipeptidyl Peptidase 4 - blood | Glucagon-Like Peptide 1 - blood | Male | Piperidones - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Cardiovascular Diseases - complications | Forkhead Transcription Factors - metabolism | Cardiovascular Diseases - blood | Proto-Oncogene Proteins c-akt - metabolism | Diabetes Mellitus, Type 2 - complications | Ventricular Dysfunction - physiopathology | Disease Models, Animal | Kidney - drug effects | Ventricular Dysfunction - complications | Cardiomegaly - blood | Cardiomegaly - physiopathology | Podocytes - pathology | Pyrimidines - pharmacology | Piperidones - pharmacology | Cardiomegaly - complications | Diabetes Mellitus, Type 2 - blood | Animals | Ventricular Dysfunction - blood | Podocytes - drug effects | Pyrimidines - therapeutic use | Mice | Diabetes Mellitus, Type 2 - drug therapy | Forkhead Box Protein O3 | Type 2 diabetes | Complications and side effects | Models | Research | Cardiovascular diseases | Risk factors | Heart | Nephrology | Syngeneic grafts | Cardiomyopathy | Kinases | Ischemia | Rodents | Animal tissues | Inhibition | Cardiology | Heart diseases | Drug dosages | Urine | Excretion | Echocardiography | Peptidase | Kidneys | Internal medicine | Complications | Diabetes mellitus | Permeability | Medicine | Inhibitors | Nephropathy | Microscopy | Fibrosis | Diabetes | Ventricle | Laboratory animals | Apoptosis | Index Medicus
Journal Article
Atherosclerosis, ISSN 0021-9150, 2005, Volume 179, Issue 1, pp. 43 - 49
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 2015, Volume 84, pp. 24 - 35
Abstract Unresolved inflammation is a major contributor to the development of heart failure following myocardial infarction (MI). Pro-resolving lipid... 
Cardiovascular | Myocardial infarction | Splenic remodeling | Resolution of inflammation | Metabololipidomics | Resolvin D1 | Neutrophils | SURVIVAL | CHRONIC HEART-FAILURE | PROTECTIVE ACTIONS | CARDIAC & CARDIOVASCULAR SYSTEMS | RESOLUTION | TISSUE | RECEPTOR | LIPID MEDIATORS | CELL BIOLOGY | THERAPY | PATHWAY | DISEASE | Cell Count | Male | Myocardial Infarction - diagnostic imaging | Spleen - drug effects | Extracellular Matrix - genetics | Inflammation - complications | Pulmonary Edema - physiopathology | Inflammation - drug therapy | Pulmonary Edema - complications | Receptors, Formyl Peptide - metabolism | Ultrasonography | Myocardial Infarction - physiopathology | Cell Polarity - drug effects | Spleen - pathology | Neutrophil Infiltration - drug effects | Ventricular Function - drug effects | Docosahexaenoic Acids - therapeutic use | Arachidonate 5-Lipoxygenase - metabolism | Docosahexaenoic Acids - chemistry | Extracellular Matrix - drug effects | Mice, Inbred C57BL | Cardiomegaly - diagnostic imaging | Cardiomegaly - drug therapy | Cardiomegaly - physiopathology | Pulmonary Edema - drug therapy | Cardiomegaly - complications | Collagen - metabolism | Docosahexaenoic Acids - pharmacology | Myocardial Infarction - complications | Macrophages - metabolism | Animals | Myocardial Infarction - drug therapy | Heart Ventricles - physiopathology | Prostaglandin-Endoperoxide Synthases - metabolism | Macrophages - drug effects | Ventricular Remodeling - drug effects | Heart Ventricles - drug effects | Inflammation | Heart attack | Index Medicus | metabololipidomics | liposomes | myocardial infarction | splenic remodeling | neutrophils | resolution of inflammation
Journal Article
Journal Article
Journal of Forensic Sciences, ISSN 0022-1198, 09/2011, Volume 56, Issue 5, pp. 1376 - 1379
Journal Article
Endocrine, ISSN 1355-008X, 3/2018, Volume 59, Issue 3, pp. 677 - 684
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2017, Volume 12, Issue 8, pp. e0183166 - e0183166
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2011, Volume 6, Issue 11, pp. e27910 - e27910
Although chronic hypoxia is a claimed myocardial risk factor reducing tolerance to ischemia/reperfusion (I/R), intermittent reoxygenation has beneficial... 
ISCHEMIA-REPERFUSION INJURY | HEART | APOPTOSIS | SILDENAFIL | PULMONARY-HYPERTENSION | NA+/CA2+ EXCHANGE | PHOSPHORYLATION | K-ATP CHANNELS | IN-VIVO | BIOLOGY | NITRIC-OXIDE | Myocardial Infarction - blood | Apoptosis - drug effects | Body Weight - drug effects | Polycythemia - blood | Cardiomegaly - pathology | Male | Polycythemia - complications | Oxygen - metabolism | Myocardial Infarction - pathology | Polycythemia - pathology | Nitric Oxide Synthase Type III - metabolism | Phosphodiesterase 5 Inhibitors - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Cyclic Nucleotide Phosphodiesterases, Type 5 - metabolism | Nitric Oxide - blood | Cell Hypoxia - drug effects | Cardiomegaly - blood | Rats | Myocardium - pathology | Cardiomegaly - enzymology | Cardiotonic Agents - pharmacology | Rats, Sprague-Dawley | Cardiomegaly - complications | Myocardial Infarction - complications | Myocardium - enzymology | Animals | Signal Transduction - drug effects | Heart | Nitrates | Diagnosis | Ischemia | Risk factors | Phosphorylation | Nitrites | Homeostasis | AKT protein | Kinases | Caspase-3 | Defects | Mimicry | Proteins | Reperfusion | Rodents | Cyclic GMP | Surgery | DNA fragmentation | Inhibition | Fitness training programs | Deoxyribonucleic acid--DNA | Phosphodiesterase | Congenital diseases | Pulmonary arteries | Coronary artery | Caspase | Cardiomyocytes | Pharmacology | Dentistry | Myocardium | Hypoxia | Sildenafil | Laboratory animals | Apoptosis | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Biomedicine & Pharmacotherapy, ISSN 0753-3322, 06/2018, Volume 102, pp. 884 - 893
The incidence of arrhythmias is the main cause of high mortality after myocardial infarction (AMI). The aim of the present study was to determine whether the... 
Stretch | Rosmarinic acid | NCX1 | Arrhythmia | Acute myocardial infarction | Hypertrophy | NCX | MEDICINE, RESEARCH & EXPERIMENTAL | OXIDATIVE STRESS | HEART-FAILURE | SIZE | MECHANISMS | ISOPROTERENOL | PROTECTS | PHARMACOLOGY & PHARMACY | HEMODYNAMIC PARAMETERS | ISCHEMIA-REPERFUSION | CARDIAC TROPONIN-I | Myocardial Infarction - blood | Tachycardia - blood | Stress, Mechanical | Male | Sodium-Calcium Exchanger - genetics | RNA, Messenger - metabolism | Arrhythmias, Cardiac - physiopathology | Depsides - pharmacology | Sodium-Calcium Exchanger - metabolism | Malondialdehyde - blood | Ventricular Premature Complexes - physiopathology | Depsides - therapeutic use | Electrocardiography | Tachycardia - complications | Cholesterol, LDL - blood | Myocardial Infarction - physiopathology | Blood Pressure - drug effects | Diastole - drug effects | Heart Ventricles - pathology | Tachycardia - drug therapy | Cardiomegaly - blood | RNA, Messenger - genetics | Cardiomegaly - drug therapy | Cardiomegaly - physiopathology | Cinnamates - pharmacology | Rats, Sprague-Dawley | Tachycardia - physiopathology | Cardiomegaly - complications | Ventricular Premature Complexes - complications | Gene Expression Regulation - drug effects | Myocardial Infarction - complications | Arrhythmias, Cardiac - drug therapy | Animals | Myocardial Infarction - drug therapy | Heart Ventricles - physiopathology | Triglycerides - blood | Cholesterol, HDL - blood | Arrhythmias, Cardiac - blood | Arrhythmias, Cardiac - complications | Ventricular Premature Complexes - blood | Cinnamates - therapeutic use | Troponin I - metabolism | Heart Ventricles - drug effects | Heart | RNA | Mortality | Heart attack | Index Medicus
Journal Article